Health technologies compromises medical products, procedures, devices, diagnostics, and public health programmes. Value needs to be addressed and assessed along the clinical development that lays out evidence generation strategy and market access.
In this intensive module, we will:

‧ Address the value and the context from various stakeholders in the process for introducing a new medical product (medicine or medical devices) to a targeted market.

‧ Emphasizes the methodology of assessment used and referenced by companies and national regulatory & reimbursement agencies to inform government policy, clinical and public health practice.

‧ Understand the regulatory processes and requirements as determinants for pharmaceuticals and medical devices; reimbursement decisions by payers or out-of-pocket payment are also major factors for the uptake of a new product, increasingly based on health technology assessment.

‧ Understand the processes and the role of decisions makers to introduce a new product or technology but also along the life cycle.